Question 3 of 6: Relevance of the Foreign-Body-Response Timeline Figure to Tissue Engineering

Question 3: Relevance of the Foreign-Body-Response Timeline Figure to Tissue Engineering (20 marks)

Question text not reproduced: the examination questions are © Engineers and Geoscientists BC. Open the official past paper (linked at the top of this page) to read the question, then follow the worked solution below.

[Figure not reproduced: Figure 3.1 — The wound-healing / foreign body response timeline: an early, sharp neutrophil peak and declining mononuclear leucocyte population (acute phase) give way to rising macrophage and neovascularization levels (chronic phase), followed by foreign body giant cell and fibroblast plateaus. See the official exam paper.]

Relevance to Tissue Engineering

This figure is the standard schematic of the host inflammatory/wound-healing response to any implanted material or device, and it is directly relevant because every tissue-engineered construct — scaffold, cell-seeded device, or acellular matrix — is, from the host's point of view, an implanted foreign material that triggers exactly this sequence. The acute phase (neutrophil influx within minutes to hours, peaking early and resolving as the initial injury response subsides) reflects the unavoidable surgical/implantation trauma itself. The chronic phase (rising macrophage numbers and neovascularization, then rising foreign body giant cells as macrophages fuse on a surface they cannot phagocytose or fully degrade) determines whether the construct will be productively remodelled or walled off. The granulation tissue phase (fibroblast activity and, ultimately, fibrosis) is the point at which the outcome is decided: either the fibroblasts deposit organized, vascularized new tissue that integrates with and supports the construct's intended function (constructive remodelling), or persistent foreign body giant cell activity drives progressive collagenous fibrous encapsulation that isolates the construct from the surrounding tissue and defeats its purpose.

Issues Tissue Engineers Should Pay Particular Attention To

Material choice and degradation kinetics: a poorly biodegradable or highly reactive material provokes sustained foreign body giant cell activity that never resolves, driving the outcome toward fibrosis; a well-matched, appropriately degradable scaffold should be resorbed and replaced by host tissue on roughly the same time-course this curve describes, so that fibroblast/new-matrix deposition is constructive rather than encapsulating. Scaffold porosity and surface chemistry influence macrophage phenotype (a more open, appropriately sized pore structure favours a pro-remodelling macrophage response over a persistently pro-inflammatory one) and therefore shift the balance between integration and fibrous walling-off. Vascularization timing is critical — the neovascularization curve must rise fast enough, and to a sufficient level, to support the metabolic demand of any seeded cells before the construct's core becomes hypoxic; this is exactly the mass-transfer concern raised for the liver (Question 1) and kidney (Question 2) constructs. The endpoint matters most for a functional construct: for a device (such as the tissue-engineered kidney of Question 2) that depends on ongoing perfusion and exchange with the surrounding tissue, a fibrous capsule is functionally catastrophic even though it is a normal, "successful" wound-healing outcome for a simple structural implant — so the desired endpoint on this curve is application-specific, and the engineer must design the material and cell components to steer the response toward the outcome the specific construct actually needs.